Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mutagenesis of GATA1 is an initiating event in Down syndrome leukemogenesis

20 May 2003

Abstract excerpt

As many as 10% of infants with Down syndrome (DS) present with transient myeloproliferative disorder (TMD) at or shortly after birth. TMD is characterized by an abundance of blasts within the peripheral blood and liver, and notably undergoes spontaneous remission in the majority of cases. TMD may be a precursor to acute megakaryoblastic leukemia (AMKL), with an estimated 30% of TMD patients developing AMKL within...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Chronic Myeloid Leukemia Treatments
Share to Sarcoma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 12560215
DOI: 10.1182/blood-2002-12-3904

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mutagenesis of GATA1 is an initiating event in Down syndrome leukemogenesisPMID 12560215Read ↗

Mutations in GATA1 in both transient myeloproliferative disorder and acute megakaryoblastic leukemia of Down syndrome.Semantic proximity Read ↗

Recent insights into the mechanisms of myeloid leukemogenesis in Down syndrome.Semantic proximity Read ↗

GATA1 mutations in Down syndrome: implications for biology and diagnosis of children with transient myeloproliferative disorder and acute megakaryoblastic leukemia.Semantic proximity Read ↗

Natural history of GATA1 mutations in Down syndrome.Semantic proximity Read ↗

Recent advances in the understanding of transient abnormal myelopoiesis in Down syndromeSemantic proximity Read ↗

Incidence and clinical implications of GATA1 mutations in newborns with Down syndrome.Semantic proximity Read ↗

GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome.Semantic proximity Read ↗

GATA1-mutant clones are frequent and often unsuspected in babies with Down syndrome: identification of a population at risk of leukemia.Semantic proximity Read ↗

Acute megakaryoblastic leukaemia (AMKL) and transient myeloproliferative disorder (TMD) in Down syndrome: a multi-step model of myeloid leukaemogenesis.Semantic proximity Read ↗

Clinical significance of preleukemic somatic GATA1 mutations in children with Down syndromeSemantic proximity Read ↗

Mutation characterization in the GATA-1 gene in patients with Down's Syndrome diagnosed with transient abnormal myelopoiesis or acute megakaryoblastic leukemia.Semantic proximity Read ↗

Analysis of GATA1 mutations and leukemogenesis in newborns with Down syndrome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.